Twelve weeks' sertraline and CBT in young people with anxiety disorders increases likelihood of no longer having the diagnosis compared with placebo or monotherapy, but residual symptoms remain

Betsy Kennard

doi:10.1136/ebmental-2012-100729

Twelve weeks' sertraline and CBT in young people with anxiety disorders increases likelihood of no longer having the diagnosis compared with placebo or monotherapy, but residual symptoms remain

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	71
Number of pages	1
Journal	Evidence-Based Mental Health
Volume	15
Issue number	3
DOIs	https://doi.org/10.1136/ebmental-2012-100729
State	Published - Aug 2012

ASJC Scopus subject areas

Psychiatry and Mental health

Access to Document

10.1136/ebmental-2012-100729

Cite this

@article{1cbfc1ed019a4225a8c84d40aa9bfac1,

title = "Twelve weeks' sertraline and CBT in young people with anxiety disorders increases likelihood of no longer having the diagnosis compared with placebo or monotherapy, but residual symptoms remain",

author = "Betsy Kennard",

year = "2012",

month = aug,

doi = "10.1136/ebmental-2012-100729",

language = "English (US)",

volume = "15",

pages = "71",

journal = "Evidence-Based Mental Health",

issn = "1362-0347",

publisher = "BMJ Publishing Group",

number = "3",

}

TY - JOUR

T1 - Twelve weeks' sertraline and CBT in young people with anxiety disorders increases likelihood of no longer having the diagnosis compared with placebo or monotherapy, but residual symptoms remain

AU - Kennard, Betsy

PY - 2012/8

Y1 - 2012/8

UR - http://www.scopus.com/inward/record.url?scp=84865189299&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865189299&partnerID=8YFLogxK

U2 - 10.1136/ebmental-2012-100729

DO - 10.1136/ebmental-2012-100729

M3 - Comment/debate

C2 - 22535558

AN - SCOPUS:84865189299

SN - 1362-0347

VL - 15

SP - 71

JO - Evidence-Based Mental Health

JF - Evidence-Based Mental Health

IS - 3

ER -

Twelve weeks' sertraline and CBT in young people with anxiety disorders increases likelihood of no longer having the diagnosis compared with placebo or monotherapy, but residual symptoms remain

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this